These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32915962)

  • 21. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants.
    Burgess S; Bowden J; Fall T; Ingelsson E; Thompson SG
    Epidemiology; 2017 Jan; 28(1):30-42. PubMed ID: 27749700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of nonrandom selection mechanisms on the causal effect estimation for two-sample Mendelian randomization methods.
    Yu Y; Hou L; Shi X; Sun X; Liu X; Yu Y; Yuan Z; Li H; Xue F
    PLoS Genet; 2022 Mar; 18(3):e1010107. PubMed ID: 35298462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avoiding collider bias in Mendelian randomization when performing stratified analyses.
    Coscia C; Gill D; Benítez R; Pérez T; Malats N; Burgess S
    Eur J Epidemiol; 2022 Jul; 37(7):671-682. PubMed ID: 35639294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mendelian randomization with fine-mapped genetic data: Choosing from large numbers of correlated instrumental variables.
    Burgess S; Zuber V; Valdes-Marquez E; Sun BB; Hopewell JC
    Genet Epidemiol; 2017 Dec; 41(8):714-725. PubMed ID: 28944551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TwoStepCisMR: A Novel Method and R Package for Attenuating Bias in
    Woolf B; Zagkos L; Gill D
    Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mendelian randomization analysis with multiple genetic variants using summarized data.
    Burgess S; Butterworth A; Thompson SG
    Genet Epidemiol; 2013 Nov; 37(7):658-65. PubMed ID: 24114802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the current state of Mendelian randomization studies: a protocol for a systematic review on methodological and clinical aspects using neurodegenerative disorders as outcome.
    Grover S; Del Greco M F; König IR
    Syst Rev; 2018 Sep; 7(1):145. PubMed ID: 30249280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caution against examining the role of reverse causality in Mendelian Randomization.
    Lutz SM; Wu AC; Hokanson JE; Vansteelandt S; Lange C
    Genet Epidemiol; 2021 Jul; 45(5):445-454. PubMed ID: 34008876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates.
    Taylor AE; Davies NM; Ware JJ; VanderWeele T; Smith GD; Munafò MR
    Econ Hum Biol; 2014 Mar; 13(100):99-106. PubMed ID: 24388127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing causal relationships using genetic proxies for exposures: an introduction to Mendelian randomization.
    Katikireddi SV; Green MJ; Taylor AE; Davey Smith G; Munafò MR
    Addiction; 2018 Apr; 113(4):764-774. PubMed ID: 28921935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator.
    Bowden J; Davey Smith G; Haycock PC; Burgess S
    Genet Epidemiol; 2016 May; 40(4):304-14. PubMed ID: 27061298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption.
    Bowden J; Del Greco M F; Minelli C; Zhao Q; Lawlor DA; Sheehan NA; Thompson J; Davey Smith G
    Int J Epidemiol; 2019 Jun; 48(3):728-742. PubMed ID: 30561657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors.
    Burgess S; Butterworth AS; Thompson JR
    J Clin Epidemiol; 2016 Jan; 69():208-16. PubMed ID: 26291580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inferring the direction of a causal link and estimating its effect via a Bayesian Mendelian randomization approach.
    Bucur IG; Claassen T; Heskes T
    Stat Methods Med Res; 2020 Apr; 29(4):1081-1111. PubMed ID: 31146640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inferring Causal Relationships Between Risk Factors and Outcomes from Genome-Wide Association Study Data.
    Burgess S; Foley CN; Zuber V
    Annu Rev Genomics Hum Genet; 2018 Aug; 19():303-327. PubMed ID: 29709202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of instrumental variable estimators for Mendelian randomization.
    Burgess S; Small DS; Thompson SG
    Stat Methods Med Res; 2017 Oct; 26(5):2333-2355. PubMed ID: 26282889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An efficient and robust approach to Mendelian randomization with measured pleiotropic effects in a high-dimensional setting.
    Grant AJ; Burgess S
    Biostatistics; 2022 Apr; 23(2):609-625. PubMed ID: 33155035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factorial Mendelian randomization: using genetic variants to assess interactions.
    Rees JMB; Foley CN; Burgess S
    Int J Epidemiol; 2020 Aug; 49(4):1147-1158. PubMed ID: 31369124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRCIP: a robust Mendelian randomization method accounting for correlated and idiosyncratic pleiotropy.
    Xu S; Fung WK; Liu Z
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33704372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mendelian randomization study of inflammatory bowel disease and bone mineral density.
    Wu F; Huang Y; Hu J; Shao Z
    BMC Med; 2020 Nov; 18(1):312. PubMed ID: 33167994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.